KMB Kimberly Clark (KMB) Insider Trading, Ownership & Congress Trades
Materials · Converted paper & paperboard prods (no contaners/boxes) · CIK 0000055785
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
841
13F, latest reported quarter
Conversions, 180 days
24
Codes C/M, not in net · $0 priced
What the filings say about KMB
Insiders, 180 days
-$689.7K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 2 sold
Latest: sale, 2026-08-18
Kimberly Clark insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, KIMBERLY CLARK CORP insiders sold a net $689.7K of stock across 57 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Feb 5, 2026.
- 1 other insider sold within 30 days.
- 841 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Controller, VP & FP&A Scribner Andrew sold about $401.3K of KMB on May 6, 2026; 1 other insider sold within 30 days and 841 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Apr 30, 2026.
- The trade is 19.1% of the 8,362 shares held after it.
- 1 other insider sold within 30 days.
- 841 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, Int'l Personal Care Chen Katy sold about $152.2K of KMB on May 4, 2026; 1 other insider sold within 30 days and 841 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on May 2, 2025.
- The trade is 21.6% of the 6,502 shares held after it.
- 1 other insider sold within 30 days.
- 841 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, Int'l Personal Care Chen Katy sold about $136.2K of KMB on Apr 30, 2026; 1 other insider sold within 30 days and 841 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Apr 9, 2025.
- +0.6% median (+0.6% mean) 90-day return after 2 previous buys.
- The trade is 100.0% of the 10,000 shares held after it.
- No other insider bought within 30 days.
- 841 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MACLIN TODD bought about $1.0M of KMB on Feb 9, 2026, the largest insider purchase at the company on our record; 841 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- No other insider sold within 30 days.
- 841 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Controller, VP & FP&A Scribner Andrew sold about $318.0K of KMB on Feb 5, 2026; 841 funds added in the latest 13F quarter.57 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$689.7K over 180 days
below 62% of Materials
Congress
no House purchase disclosed in the last 12 months
Funds
841 funds bought in last quarter
more than 99% of Materials
Revenue
-2.1% year over year
below 61% of Materials
Margin
12.3% net margin
more than 83% of Materials
Buybacks
$141.0M repurchased, FY to 2025-12-31
more than 70% of Materials
Short interest
16.1% of the float short (float per yahoo 2026-10-26) · 14.2 days to cover · settled 2026-09-30
more than 96% of Materials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch KMB
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-4.8%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns KMB: institutional holders (13F)
13F holdings, latest reported quarter
32,321,354 sh
$3.5B
21,661,695 sh
$2.4B
21,081,552 sh
$2.3B
16,099,649 sh
$1.8B
13,133,613 sh
$1.4B
Congress trades in KMB
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-08-18 · disclosed 14 days later
$1,001 - $15,000
Sold 2025-11-12 · disclosed 33 days later
$1,001 - $15,000
Sold 2025-07-16 · disclosed 28 days later
$1,001 - $15,000
Bought 2025-07-10 · disclosed 34 days later
$1,001 - $15,000
Sold 2025-05-15 · disclosed 16 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
KMB planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
KMB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Neuberger Option Strategy ETF
$38.5M position · as of 2026-05-31
8.6%
Camelot Event Driven Fund
$6.3M position · as of 2026-06-30
5.3%
Nuance Concentrated Value Fund
$2.2M position · as of 2026-07-31
5.2%
Integrity Dividend Summit Fund
$765.2K position · as of 2026-07-31
4.8%
VictoryShares Dividend Accelerator ETF
$8.9M position · as of 2026-06-30
3.7%
Invesco S&P 500 Equal Weight Consumer Staples ETF
$8.0M position · as of 2026-07-31
3.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Clinical pipeline
3 registered trials, 0 still running (ClinicalTrials.gov).
A status change is dated here weeks before the press release.
3
Not applicable
0 active
What changed recently
Tampon Safety-in-Use Study
2026-09-24 · Completion moved 2026-08-31 → 2026-09-15
Not applicable
Tampon Safety-in-Use Study
2026-09-24 · Recruiting → Completed
Not applicable
Matched by sponsor name. Trials run under a subsidiary's
own name are not included.
Executive pay vs shareholder return · Hsu
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$15.3M
$9.2M
$5.3M
-10%
+41%
2024
$16.4M
$23.8M
$5.8M
+13%
+51%
2023
$16.5M
$20.8M
$5.1M
+1%
+31%
2022
$14.6M
$23.4M
$5.5M
+9%
+31%
2021
$12.0M
$3.3M
$4.6M
+11%
+31%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $689.7K sold by insiders over 180 days, 841 funds added last quarter. Each figure is a federal filing, dated the day it went public.
KMB financials
Revenue growth
-2.1%
XBRL, annual
Net margin
12.3%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM KMB
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | $20.4B |
| FY Dec 2022 | $20.2B |
| FY Dec 2021 | $19.4B |
| Jun 2026 | $4.2B |
| Mar 2026 | $4.2B |
| Dec 2025 | $4.1B |
| Sep 2025 | $4.2B |
| Jun 2025 | $4.2B |
| Mar 2025 | $4.8B |
| Dec 2024 | $4.1B |
| Sep 2024 | $5.0B |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM KMB
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +8.6% |
| FY Dec 2022 | +9.6% |
| FY Dec 2021 | +9.3% |
| Jun 2026 | +8.2% |
| Mar 2026 | +16.0% |
| Dec 2025 | +12.2% |
| Sep 2025 | +10.7% |
| Jun 2025 | +12.2% |
| Mar 2025 | +11.7% |
| Dec 2024 | +10.9% |
| Sep 2024 | +18.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.8B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM KMB
| FY Dec 2025 | $1.6B |
| FY Dec 2024 | $2.5B |
| FY Dec 2023 | $2.8B |
| FY Dec 2022 | $1.9B |
| FY Dec 2021 | $1.7B |
| Jun 2026 | $556.0M |
| Mar 2026 | $321.0M |
| Dec 2025 | $575.0M |
| Sep 2025 | $368.0M |
| Jun 2025 | $573.0M |
| Mar 2025 | $123.0M |
| Dec 2024 | $608.0M |
| Sep 2024 | $798.0M |
At each fiscal year end
Single quarter
Debt to equity
3.72x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity KMB
| FY Dec 2025 | 4.77x |
| FY Dec 2024 | 8.83x |
| FY Dec 2023 | 8.69x |
| FY Dec 2022 | 15.40x |
| FY Dec 2021 | 16.68x |
| Jun 2026 | 3.72x |
| Mar 2026 | 3.94x |
| Dec 2025 | 4.77x |
| Sep 2025 | 5.48x |
| Jun 2025 | 5.70x |
| Mar 2025 | 6.58x |
| Dec 2024 | 8.83x |
| Sep 2024 | 5.80x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.51x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt KMB
| FY Dec 2025 | 0.39x |
| FY Dec 2024 | 0.44x |
| FY Dec 2023 | 0.45x |
| FY Dec 2022 | 0.32x |
| FY Dec 2021 | 0.32x |
| Jun 2026 | 0.51x |
| Mar 2026 | 0.45x |
| Dec 2025 | 0.39x |
| Sep 2025 | 0.36x |
| Jun 2025 | 0.40x |
| Mar 2025 | 0.43x |
| Dec 2024 | 0.44x |
| Sep 2024 | 0.49x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+129.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity KMB
| FY Dec 2025 | +172.6% |
| FY Dec 2024 | +290.0% |
| FY Dec 2023 | +241.3% |
| FY Dec 2022 | +364.6% |
| FY Dec 2021 | +318.2% |
| Jun 2026 | +129.4% |
| Mar 2026 | +146.3% |
| Dec 2025 | +172.6% |
| Sep 2025 | +150.5% |
| Jun 2025 | +201.9% |
| Mar 2025 | +229.8% |
| Dec 2024 | +290.0% |
| Sep 2024 | +265.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets KMB
| FY Dec 2025 | +12.0% |
| FY Dec 2024 | +15.0% |
| FY Dec 2023 | +10.0% |
| FY Dec 2022 | +10.8% |
| FY Dec 2021 | +10.3% |
| Jun 2026 | +11.1% |
| Mar 2026 | +12.7% |
| Dec 2025 | +12.0% |
| Sep 2025 | +11.6% |
| Jun 2025 | +14.3% |
| Mar 2025 | +14.8% |
| Dec 2024 | +15.0% |
| Sep 2024 | +15.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+23.4%
operating income after a 32.7% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital KMB
| FY Dec 2025 | +22.2% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +21.5% |
| FY Dec 2022 | +23.2% |
| FY Dec 2021 | +24.3% |
| Jun 2026 | +23.4% |
| Mar 2026 | +22.0% |
| Dec 2025 | +22.2% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+23.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed KMB
| FY Dec 2025 | +24.1% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +18.3% |
| FY Dec 2022 | +21.3% |
| FY Dec 2021 | +23.1% |
| Jun 2026 | +23.8% |
| Mar 2026 | +25.2% |
| Dec 2025 | +24.1% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | +26.2% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
18.73x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing KMB
| FY Dec 2025 | 16.62x |
| FY Dec 2024 | 17.36x |
| FY Dec 2023 | 23.32x |
| FY Dec 2022 | 23.73x |
| FY Dec 2021 | 26.76x |
| Jun 2026 | 18.67x |
| Mar 2026 | 15.14x |
| Dec 2025 | 16.62x |
| Sep 2025 | 21.04x |
| Jun 2025 | 17.76x |
| Mar 2025 | 19.38x |
| Dec 2024 | 17.36x |
| Sep 2024 | 18.43x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$42.2B
market value at close 2026-10-23 on 2026-07-28 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value KMB
| FY Dec 2025 | $40.0B |
| FY Dec 2024 | $50.1B |
| FY Dec 2023 | $47.9B |
| FY Dec 2022 | $53.8B |
| FY Dec 2021 | $56.4B |
| Jun 2026 | $42.0B |
| Mar 2026 | $38.6B |
| Dec 2025 | $40.0B |
| Sep 2025 | $47.9B |
| Jun 2025 | $49.4B |
| Mar 2025 | $53.9B |
| Dec 2024 | $50.1B |
| Sep 2024 | $54.3B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.0%
TTM free cash flow over market value at close 2026-10-23
FCF yield KMB
| FY Dec 2025 | +4.9% |
| FY Dec 2024 | +5.8% |
| FY Dec 2023 | +6.8% |
| FY Dec 2022 | +4.1% |
| FY Dec 2021 | +3.6% |
| Jun 2026 | +5.0% |
| Mar 2026 | +5.7% |
| Dec 2025 | +4.9% |
| Sep 2025 | +4.1% |
| Jun 2025 | +4.9% |
| Mar 2025 | +5.1% |
| Dec 2024 | +5.8% |
| Sep 2024 | +6.1% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -19%, PEG needs growth
PEG, trailing KMB
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.39x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 3.34x |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | 2.40x |
| Mar 2025 | 0.56x |
| Dec 2024 | 0.39x |
| Sep 2024 | 0.38x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $16.4B | $20.1B | $20.4B | $20.2B |
| Gross profit | $5.9B | $6.3B | $6.3B | $5.5B |
| Operating income | $2.4B | $2.7B | $1.9B | $2.3B |
| Net income | $2.0B | $2.5B | $1.8B | $1.9B |
| EPS (diluted) | 6.07 | 7.55 | 5.21 | 5.72 |
| Operating cash flow | $2.8B | $3.2B | $3.5B | $2.7B |
| Cash | $688.0M | $1.0B | $1.1B | $427.0M |
| Long-term debt | $6.5B | $6.9B | $7.4B | $7.6B |
| Buybacks | $141.0M | $1.0B | $225.0M | $100.0M |
| Dividends paid | $1.7B | $1.6B | $1.6B | $1.6B |
SEC XBRL, fiscal years, as known on 2026-10-27
KMB Stock Sonar score 6/7 axes
Find similar shapesCompareKMB ranks highest on profitability (91st percentile) and institutional and government (67th), and lowest on risk and compliance (9th), among Materials peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
KMB filings, in plain words
Are Kimberly Clark insiders buying or selling KMB?
In the 180 days to 2026-10-27, Kimberly Clark insiders were net sellers, a net $689.7K across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded KMB?
Yes. In the year to 2026-10-27, 0 House members disclosed buying KMB and 2 House members disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-18.
Read the full summary
In the 180 days to 2026-10-27, Kimberly Clark insiders were net sellers of KMB, a net $689.7K across purchases and sales reported on Form 4 by 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 0 members of Congress disclosed buying KMB and 2 members disclosed selling it; the latest on record is a sale by Kevin Hern dated 2026-08-18. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
